98 related articles for article (PubMed ID: 11115722)
1. Immunogenicity of a foreign peptide expressed within a capsid protein of an attenuated coxsackievirus.
Halim SS; Ostrowski SE; Lee WT; Ramsingh AI
Vaccine; 2000 Nov; 19(7-8):958-65. PubMed ID: 11115722
[TBL] [Abstract][Full Text] [Related]
2. Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera.
Reimann BY; Zell R; Kandolf R
J Virol; 1991 Jul; 65(7):3475-80. PubMed ID: 1645779
[TBL] [Abstract][Full Text] [Related]
3. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
[TBL] [Abstract][Full Text] [Related]
4. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
5. A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
Halim S; Ramsingh AI
Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras.
McPhee F; Zell R; Reimann BY; Hofschneider PH; Kandolf R
Virus Res; 1994 Nov; 34(2):139-51. PubMed ID: 7531922
[TBL] [Abstract][Full Text] [Related]
7. Immunodominance of a recombinant T-cell epitope depends on its molecular environment.
Leclerc C; Martineau P; Charbit A; Lo-Man R; Dériaud E; Hofnung M
Mol Immunol; 1993 Dec; 30(17):1561-72. PubMed ID: 8247026
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector.
Kim DS; Cho YJ; Kim BG; Lee SH; Nam JH
Vaccine; 2010 Feb; 28(5):1234-40. PubMed ID: 19941986
[TBL] [Abstract][Full Text] [Related]
9. Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides.
Auvinen P; Mäkelä MJ; Roivainen M; Kallajoki M; Vainionpää R; Hyypiä T
APMIS; 1993 Jul; 101(7):517-28. PubMed ID: 7691097
[TBL] [Abstract][Full Text] [Related]
10. Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies.
Borrego B; García-Ranea JA; Douglas A; Brocchi E
J Gen Virol; 2002 Jun; 83(Pt 6):1387-1395. PubMed ID: 12029154
[TBL] [Abstract][Full Text] [Related]
11. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.
Martineau P; Guillet JG; Leclerc C; Hofnung M
Gene; 1992 Apr; 113(1):35-46. PubMed ID: 1373395
[TBL] [Abstract][Full Text] [Related]
12. DNA immunization of mice against the VP1 capsid protein of coxsackievirus B4.
Toniolo A; Falcone V; Bernasconi C; Basolo F; Speziale P; Onodera T
Scand J Immunol; 2002 Nov; 56(5):448-55. PubMed ID: 12410794
[TBL] [Abstract][Full Text] [Related]
13. Identification of Mengo virus T helper cell epitopes.
Muir S; Kobasa D; Bittle J; Scraba D
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2925-36. PubMed ID: 7525861
[TBL] [Abstract][Full Text] [Related]
14. A therapeutic HIV vaccine using coxsackie-HIV recombinants: a possible new strategy.
Halim SS; Collins DN; Ramsingh AI
AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1551-8. PubMed ID: 11054268
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA).
Chen M; Song Y; Fan Z; Jiang P; Hu B; Xue J; Wei H; Wang F
Virus Res; 2014 Apr; 183():15-22. PubMed ID: 24457072
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles.
Sedlik C; Sarraseca J; Rueda P; Leclerc C; Casal I
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2361-8. PubMed ID: 7561778
[TBL] [Abstract][Full Text] [Related]
17. Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria.
van der Werf S; Charbit A; Leclerc C; Mimic V; Ronco J; Girard M; Hofnung M
Vaccine; 1990 Jun; 8(3):269-77. PubMed ID: 1694613
[TBL] [Abstract][Full Text] [Related]
18. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
[TBL] [Abstract][Full Text] [Related]
19. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
20. T cell epitopes in coxsackievirus B4 structural proteins concentrate in regions conserved between enteroviruses.
Marttila J; Hyöty H; Vilja P; Härkönen T; Alho A; Roivainen M; Hyypiä T; Ilonen J
Virology; 2002 Feb; 293(2):217-24. PubMed ID: 11886241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
